RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
!Importante!
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
RT @DrPontecarlosi: 👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y evento…
👁🗨REDUCE-IT🆕data 1er estudio con Rx hipolipemiantes no Estatinas(EPA Omega3) que muestra ⬇️ revascularizacion y eventos isquemicos totales http:// https://t.co/cQQ0bh2bVg @SIAC_cardio @SIAC_cardio.@torresviera @mencardio.@detenelriesgo @cardioprevanz @a
RT @erlesen: Effects of Icosapent Ethyl on Total Ischemic Events https://t.co/ELFz8PfidK Ω3-Fischöl schützt vor Herzinfarkt und Schlaganfal…
RT @dkenigsberg: Treating triglycerides reduces ischemia with this cheap and effective therapy: https://t.co/PGnlnxQ75K
Treating triglycerides reduces ischemia with this cheap and effective therapy: https://t.co/PGnlnxQ75K
Effects of Icosapent Ethyl on Total Ischemic Events https://t.co/PoWhS8ErqV
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/68b6LhsWkY
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/68b6LhsWkY
RT @tripdatabase: New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/l3GyjriM2P
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/68b6LhsWkY
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/l3GyjriM2P
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/68b6LhsWkY
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/68b6LhsWkY
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/68b6LhsWkY
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/l3GyjriM2P
New2Trip: Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/68b6LhsWkY
RT @doctorheart00: En pacientes con enfermedad coronaria y aumento de triglicéridos el eicosapentyl redujo 30% la enfermedad coronaria sob…
Paradigm shift, I guess we have to care about triglycerides for CVD not just pancreatitis. Would love to see another study to verify this finding...
RT @doctorheart00: En pacientes con enfermedad coronaria y aumento de triglicéridos el eicosapentyl redujo 30% la enfermedad coronaria sob…
RT @JKSpoonAmore: TY @DLBHATTMD for discussing REDUCE-IT & more today at @IUSMDeptMed for the @dzipes Visiting Professorship today! https:/…
RT @JKSpoonAmore: TY @DLBHATTMD for discussing REDUCE-IT & more today at @IUSMDeptMed for the @dzipes Visiting Professorship today! https:/…
TY @DLBHATTMD for discussing REDUCE-IT & more today at @IUSMDeptMed for the @dzipes Visiting Professorship today!
RT @DLBHATTMD: Now published in @JACCJournals online from REDUCE-IT: Effects of Icosapent Ethyl on Total Ischemic Events https://t.co/O62me…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @doctorheart00: En pacientes con enfermedad coronaria y aumento de triglicéridos el eicosapentyl redujo 30% la enfermedad coronaria sob…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @doctorheart00: En pacientes con enfermedad coronaria y aumento de triglicéridos el eicosapentyl redujo 30% la enfermedad coronaria sob…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @doctorheart00: En pacientes con enfermedad coronaria y aumento de triglicéridos el eicosapentyl redujo 30% la enfermedad coronaria sob…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
En pacientes con enfermedad coronaria y aumento de triglicéridos el eicosapentyl redujo 30% la enfermedad coronaria sobre el uso de estátinas.
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
RT @JACCJournals: In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%.…
In statin-treated patients with high triglyceride levels with #CVD or DM2, icosapent ethyl reduced CVD event rate by 30%. https://t.co/bYHK9LYCzD #JACC @DLBhattMD https://t.co/iSnBueeyBj
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT https://t.co/QbBirHBnT9
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @mbotana: "Among statin-treated patients with elevated triglycerides and cardiovascular disease or diabetes, multiple statistical models…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Are you using icosapent ethyl in your high triglyceride patients? https://t.co/N1hF9p0EWJ #JACC
RT @JohnCappello: $AMRN https://t.co/e3q5f46aoa
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
$AMRN
RT @JACCJournals: Are you using icosapent ethyl in your high triglyceride patients? https://t.co/N1hF9p0EWJ #JACC
The reason for Vascepa ‘s ongoing growth. #AMRN
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Are you using icosapent ethyl in your high triglyceride patients? https://t.co/N1hF9p0EWJ #JACC
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @SharonAConklin: #Vascepa $AMRN https://t.co/taFRwWl4RZ Make sure to let your patient know about the manufacturers copay coupon. https…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
#Vascepa $AMRN https://t.co/taFRwWl4RZ Make sure to let your patient know about the manufacturers copay coupon.
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
RT @JACCJournals: Are you using icosapent ethyl in your high triglyceride patients? https://t.co/N1hF9p0EWJ #JACC
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
Are you using icosapent ethyl in your high triglyceride patients? https://t.co/N1hF9p0EWJ #JACC
RT @JACCJournals: Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and t…
Is it time to REDUCE-IT? New #JACC manuscript found large, statistically significant reductions in first, recurrent and total ischemic events with icosapent ethyl. https://t.co/N1hF9p0EWJ @DLBhattMD https://t.co/2s3Lp0tEQ7
RT @DLBHATTMD: Now published in @JACCJournals online from REDUCE-IT: Effects of Icosapent Ethyl on Total Ischemic Events https://t.co/O62me…
RT @krychtiukmd: High-dose Icosapent Ethyl (EPA) further reduced total ischemic events (not just 1st events) - a prespecified analysis of R…
RT @krychtiukmd: High-dose Icosapent Ethyl (EPA) further reduced total ischemic events (not just 1st events) - a prespecified analysis of R…
RT @krychtiukmd: High-dose Icosapent Ethyl (EPA) further reduced total ischemic events (not just 1st events) - a prespecified analysis of R…
RT @krychtiukmd: High-dose Icosapent Ethyl (EPA) further reduced total ischemic events (not just 1st events) - a prespecified analysis of R…
RT @krychtiukmd: High-dose Icosapent Ethyl (EPA) further reduced total ischemic events (not just 1st events) - a prespecified analysis of R…
RT @krychtiukmd: High-dose Icosapent Ethyl (EPA) further reduced total ischemic events (not just 1st events) - a prespecified analysis of R…
RT @krychtiukmd: High-dose Icosapent Ethyl (EPA) further reduced total ischemic events (not just 1st events) - a prespecified analysis of R…
RT @CBallantyneMD: Important to consider time to first event and all events when evaluating preventive therapies for ASCVD. #prevention #tr…
Effects of Icosapent Ethyl on Total Ischemic Events https://t.co/KMxfPSB4h5